Preliminary evidence of attenuation of the disruptive effects of the NMDA glutamate receptor antagonist, ketamine, on working memory by pretreatment with the group II metabotropic glutamate receptor agonist, LY354740, in healthy human subjects

✍ Scribed by John H. Krystal; Walid Abi-Saab; Edward Perry; D. Cyril D’Souza; Nianjin Liu; Ralitza Gueorguieva; Lisa McDougall; Tracy Hunsberger; Aysenil Belger; Louise Levine; Alan Breier

• Publisher: Springer
• Year: 2004
• Tongue: English
• Weight: 155 KB
• Volume: 179
• Category: Article
• ISSN: 0033-3158
• DOI: 10.1007/s00213-004-1982-8